Transformations of the Vaska-type complex trans-[RhCl(CO)(PTA)2] (PTA = 1,3,5-triaza-7-phosphaadamantane) during stepwise addition of HCl: Synthesis, characterization and crystal structure of trans-[RhCl2(PTA)(PTAH)]

The new aqua-soluble rhodium(I) complex trans-[RhCl₂(PTA)(PTAH)] (1) {PTAH = N-protonated form of 1,3,5-triaza-7-phosphaadamantane (PTA)} has been synthesized via the reaction of trans-[RhCl(CO)(PTA)₂] with aqueous HCl or N-chlorosuccinimide, or by the treatment of RhCl₃ with PTA. Compound 1 has been characterized by IR, ¹H and ³¹P{H} NMR spectroscopies, ESI-MS(+), elemental and single crystal X-ray diffraction analyses, the latter showing a square planar {RhCl₂P₂} geometry. Besides, the stepwise addition of diluted HCl to an aqueous solution of trans-[RhCl(CO)(PTA)₂] has been monitored by ³¹P{¹H} NMR and ESI-MS(+) techniques, allowing to detect a number of intermediate Rh(I) species.     

A series of thiolato-bridged di- and trinuclear complexes derived from [Tp∗Rh(SPh)2(MeCN)] (Tp∗ = hydrotris(3,5-dimethylpyrazol-1-yl)borate)

Treatment of the Rh(III) complex [Tp∗Rh(SPh)₂(MeCN)] (1) with a series of late transition metal complexes resulted in the formations of thiolate-bridged di- and trinuclear complexes, which include the Rh(III)-Rh(I) complexes, [Tp∗RhCl(μ-SPh)₂Rh(cod)] (2) and [Tp∗RhCl(μ-SPh)₂Rh(PPh₃)₂], the Rh(III)-Pd(II) complexes, [Tp∗RhCl(μ-SPh)₂Pd(η³-C₃H₅)] (4), [{Tp∗Rh(MeCN)}(μ-SPh)₂PdCl₂] (5), and [{Tp∗RhCl(μ-SPh)₂}₂Pd] (6), and the Rh(III)-Pt(II) complex [{Tp∗RhCl(μ-SPh)₂}₂Pt] (7). Early-late transition metal complexes containing the Rh(III)-Re(I) and Rh(III)-Mo(0) metal centers, [Tp∗RhCl(μ-SPh)₂Re(CO)₄] and [{Tp∗Rh(CO)}(μ-SPh)₂Mo(CO)₄] were also prepared from 1. The X-ray analysis has been carried out to confirm the structures for 2, 4, 5, 6, and 7.     

Preparation, spectroscopy, X-ray analysis, and water-solubility studies of the first bis-PTA (PTA = 1,3,5-triaza-7-phosphaadamantane) derivatives

The bis-phosphines, 1,1′-[1,2-phenylenebis(methylene)]bis-3,5-diaza-1-azonia-7-phosphatricyclo[3.3.1.1]decane dibromide (1), 1,1′-[1,3-arenebis(methylene)]bis-[3,5-diaza-1-azonia-7-phosphatricyclo [3.3.1.1]decane dibromide (arene = phenyl (2), tolyl (3), anisolyl (4)), and 1,1′-[1,4-phenylenebis(methylene)]bis-3,5-diaza-1-azonia-7-phosphatricyclo[3.3.1.1]decane dibromide (5) were prepared in over 90% yield by refluxing 1,2-bis(bromomethyl)benzene, 1,3-bis(bromomethyl)benzene, 1,3-bis(bromomethyl)-5-methyl-benzene, 1,3-bis(bromomethyl)-5-methoxy-benzene, and 1,4-bis(bromomethyl)benzene with 1,3,5-triaza-7-phosphaadamantane (PTA) in acetone or chloroform. Compounds 1-5 are the first phosphines reported that contain two PTA moieties. All five compounds were characterized by ESI-MS, elemental analysis, ¹H, ¹³C, and ³¹P NMR spectroscopy, while 3 and 4 were additionally analyzed via single crystal X-ray diffraction. The relative positions of the PTA units on the aromatic ring as well as the substituents of the ring had a pronounced effect on the water-solubilities of the systems. The ortho compound (1, 2000 mg/mL) was more than two orders of magnitude more soluble than the para compound (5, 12.5 mg/mL). The meta substituted phenyl (2) and tolyl (3) compounds had solubilities (810 mg/mL) that were more than triple that of PTA (235 mg/mL) while the anisolyl analog (4) was half as soluble (121 mg/mL).     

Bis(pyrazolyl) palladium(II), platinum(II) and gold(III) complexes: Syntheses, molecular structures and substitution reactions with l-cysteine

A series of pyrazolyl palladium(II), platinum(II) and gold(III) complexes, [PdCl₂(3,5-R₂bpza)] {R = H (1), R = Me (2), bpza = bis-pyrazolyl acetic acid}, [PtCl₂(3,5-R₂bpza)] {R = H (3a), R = Me (4)}, [AuCl₂(3,5-R₂bpza)]Cl {R = H (5a), R = Me (6a)} and [PdCl₂(3,5-R₂bpzate)] {R = Me (7)} have been synthesised and structurally characterised. Single crystal X-ray crystallography showed that the pyrazolyl ligands exhibit N^N-coordination with the metals. Anticancer activities of six complexes 1-6a were investigated against CHO cells and were found to have low activities. Substitution reactions of selected complexes 1, 2, 3a and 5a with l-cysteine show that the low anticancer activities compounds and that the rate of substitution with sulfur-containing compounds is not the cause of the low anticancer activities.     

Influence of the phosphine arrangement on the reactivity of palladium(II) and platinum(II) polyphosphine complexes with copper(I) chloride

The distorted square-planar complexes [Pd(PNHP)Cl]Cl (1) (PNHP = bis[2-(diphenylphosphino)ethyl]amine), [M(P₃)Cl]Cl [P₃ = bis[2-(diphenylphosphino)ethyl]phenylphosphine; M = Pd (2), Pt (3)] and [Pt(NP₃)Cl]Cl (5) (NP₃ = tris[2-(diphenylphosphino)ethyl]amine), coexisting in the later case with a square-pyramidal arrangement, react with one equivalent of CuCl to give the mononuclear heteroionic systems [M(L)Cl](CuCl₂) [L = PNHP, M = Pd (1a); L = P₃, M = Pd (2a), Pt (3a); L = NP₃, M = Pt (5a)]. The crystal structure of 3a confirms that Pt(II) retains the distorted square-planar geometry of 3 in the cation with P₃ acting as tridentate chelating ligand, the central P atom being trans to one chloride. The counter anion is a nearly linear dichlorocuprate(I) ion. However, the five-coordinate complexes [Pd(NP₃)Cl]Cl (4), [M(PP₃)Cl]Cl (M = Pd (6), Pt (7); PP₃ = tris[2-(diphenylphosphino)ethyl] phosphine) containing three fused five-membered chelate rings undergo a ring-opening by interaction with one (4, 6, 7) and two (6, 7) equivalents of CuCl with formation of neutral MCu(L)Cl₃ [L = NP₃, M = Pd (4a); L = PP₃, M = Pd (6a), Pt (7a)] and ionic [MCu(PP₃)Cl₂](CuCl₂) [M = Pd (6b), Pt (7b)] compounds, respectively. The heteronuclear systems were shown by ³¹P NMR to have structures where the phosphines are acting as tridentate chelating ligands to M(II) and monodentate bridging to Cu(I). Further additions of CuCl to the neutral species 6a and 7a in a 1:1 ratio resulted in the achievement of the ionic complexes 6b and 7b with ions as counter anions. It was demonstrated that the formation of heterobimetallic or just mononuclear mixed salt complexes was clearly influenced by the polyphosphine arrangement with the tripodal ligands giving the former compounds. However, complexes [M(NP₃)Cl]Cl constitute one exception and the type of reaction undergone versus CuCl is a function of the d⁸ metal centre.     

One-pot syntheses of alkenyl-phosphonio complexes of ruthenium(II), rhodium(III) and iridium(III) bearing p-cymene or pentamethylcyclopentadienyl groups

Reaction of [(p-cymene)RuCl₂(PPh₃)] (1) or [Cp^∗MCl₂(PPh₃)] (Cp^∗ = C₅Me₅) (3a: M = Rh; 4a: M = Ir) with 1-alkynes and PPh₃ were carried out in the presence of KPF₆, generating the corresponding alkenyl-phosphonio complexes, [(p-cymene)RuCl(PPh₃){CHCR(PPh₃)}](PF₆) (2a: R = Ph; 2b: R = p-tolyl) or [Cp^∗MCl(PPh₃){CHCPh(PPh₃)}](PF₆) (5: M = Rh; 6: M = Ir). Similar reactions of complexes [Cp^∗RhCl₂(L¹)] (3a: L¹ = PPh₃; 3c: L¹ = P(OMe)₃) with L² (L² = PPh₃, PMePh₂, P(OMe)₃) gave [Cp^∗RhCl(L¹)(L²)](PF₆) (7bb: L¹ = L² = PMePh₂; 7ca: L¹ = P(OMe)₃, L² = PPh₃; 7cc: L¹ = L² = P(OMe)₃). Alkenyl-phosphonio complex 5 was treated with P(OMe)₃ or 2,6-xylyl isocyanide, affording [Cp^∗RhCl(L){CHCPh(PPh₃)}](PF₆) (8a: L = P(OMe)₃; 8b: L = 2,6-xylNC). X-ray structural analyses of 2a, 6 and 8a revealed that the phosphonium moiety bonded to the C_β atom of the alkenyl group are E configuration.     

Synthesis, structure and antitumor activity of [RhCl3(N-N)(DMSO)] polypyridyl complexes

The [RhCl₃(N-N)(DMSO)] complexes, the N-N being 2,2′-bipyridine (1), 1,10-phenanthroline (2), 4,7-diphenyl-1,10-phenanthroline (3), 4,4′-dimethyl-2,2′-bipyridine (4) and 1,10-phenanthroline-5,6-dione (5), have been synthesized and characterized with spectroscopic methods. The compounds 2-5 adopt mer- and complex 1fac-structure. The molecular and electronic structure studies of mer- and fac-complexes with bpy and phen ligands at the DFT B3LYP level with 3-21G^∗∗ basis set showed that mer-isomers are more stable. The cytostatic activity of the [RhCl₃(N-N)(DMSO)] complexes against Caco-2 and A549 tumor cells have been studied. Their antibacterial activity have also been investigated. It has been found that the very promising biological activity show complexes 2, 3 and 4.     

Bis(cyclopentadienyl) zirconium(IV) amides as possible precursors for low pressure CVD and plasma-enhanced ALD

Low pressure chemical vapour deposition (LPCVD) of [ZrCp₂(NMe₂)₂] (1), [ZrCp₂(η²-MeNCH₂CH₂NMe)] (2), [ZrCp′₂(NMe₂)₂] (3) and [ZrCp′₂(NEt₂)₂] (4) (Cp = η⁵-cyclopentadienyl, Cp′ = η⁵-monomethylcyclopentadienyl), onto glass substrates at 600 °C, afforded highly reflective and adhesive films of zirconium carbide and amorphous carbon. Powder XRD indicated that the films were largely amorphous, although small, broad peaks accounting for ZrC and ZrO₂ were present, suggesting that the remaining carbon was due to amorphous deposits from the cyclopentadienyl ligands. SEM images showed an island-growth mechanism with distinct crevices between the concentric nodules. Plasma-enhanced atomic layer deposition (PEALD) of compounds 1 and 2 showed that the precursors were not sufficiently stable or volatile to give a good rate of film growth.     

The complexes: RhCl(P-N)(THP), where P-N is P,N-chelated o-diphenylphosphino-N,N-dimethylaniline and THP is tris(hydroxymethyl)phosphine, and RhCl[(O)P-N][THP(O)] containing O-bonded phosphine oxides

The complex RhCl(P-N)(THP) (1) is synthesized under argon from RhCl(cod)(THP) and P-N, and is structurally characterized; P-N = P,N-chelated o-diphenylphosphino-N,N-dimethylaniline, THP = tris(hydroxymethyl)phosphine, and cod = 1,5-cyclo-octadiene. The corresponding synthesis in air yields RhCl[(O)P-N][THP(O)] (2), containing O-bonded phosphine oxide ligands.     

Synthesis and structural determination of new octaethylporphyrin iron(III) complexes containing cyanamide derivatives as axial ligand

The reactions of heme, [OEPFeCl] where OEP is the dianion of octaethylporphyrin, with phenylcyanamide (pcyd) ligands have been studied. Four new porphyrin complexes, [OEPFe(L)] (L = pcyd (2), 2-Clpcyd (3), 2-Mepcyd (4), 2,4-Me₂pcyd (5)), have been isolated and characterized by spectroscopic methods. ¹H NMR spectroscopy reveals that the species [OEPFe(L)] are paramagnetic and iron is five-coordinate. The structure of [OEPFe(pcyd)] (2) has been determined by X-ray diffraction analysis. The four Fe-N, bond distances have average values of 2.062 Å. The average displacement of the iron(III) atom from the mean porphinato core is 0.45 Å. Electrochemical of [OEPFe(L)] (L = pcyd (2), 2-Clpcyd (3), 2-Mepcyd (4), 2,4-Me₂pcyd (5)) have been studied by cyclic voltammetry.     

Hydrogen-bonded copper(II) and nickel(II) complexes and coordination polymeric structures containing reduced Schiff base ligands

Complexes [Cu(HSas)(H₂O)] · 2H₂O (H₃Sas = N-(2-hydroxybenzyl)-l-aspartic acid) (1), [Cu(HMeSglu)(H₂O)] · 2H₂O (H₃MeSglu = (N-(2-hydroxy-5-methylbenzyl)-l-glutamic acid) (2), [Cu₂(Smet)₂] (H₂Smet = (N-(2-hydroxybenzyl)-l-methionine) (3), [Ni(HSas)(H₂O)] (4), [Ni₂(Smet)₂(H₂O)₂] (5), and [Ni(HSapg)₂] (H₂Sapg = (N-(2-hydroxybenzyl)-l-aspargine) (6) have been synthesized and characterized by chemical and spectroscopic methods. Structural determination by single crystal X-ray diffraction studies revealed 1D coordination polymeric structures in 2 and 4, and hydrogen-bonded network structure in 5 and 6. In contrast to previously reported coordination compounds with similar ligands, the phenol remains protonated and bonded to the metal ions in 2 and 4, and also probably in 1. However, the phenolic group is non-bonded in 6.     

Hydrogen-halide versus alkyl-halide oxidative addition in dimethyl platinum(II) complexes: Crystal structure of [PtBr2(bpy)]

Dimethyl platinum(II) complexes [PtMe₂(NN)] {NN = bu₂bpy (4,4′-di-tert-butyl-2,2′-bipyridine) (1a), bpy (2,2′-bipyridine) (1b), phen (1,10-phenanthroline) (1c)} reacted with commercial 3-bromo-1-propanol in the presence of 1,3-propylene oxide to afford cis, trans- [PtBrMe₂{(CH₂)₃OH}(NN)] (NN = bu₂bpy (2a), bpy (2b), phen (2c)). On the other hand, [PtMe₂(NN)] (1a)-(1b) reacted with the trace of HBr in commercial 3-bromo-1-propanol to give [PtBr₂(NN)] (NN = bu₂bpy (3a), bpy (3b)). The reaction pathways were monitored by ¹H NMR at various temperatures. Treatment of 1a-1b with a large excess of 3-bromo-1-propanol at −80 °C gave the corresponding methyl(hydrido)platinum(IV) complexes [PtBr(H)Me₂(NN)] (NN = bu₂bpy (4a), bpy (4b)) via the oxidative addition of dimethyl platinum(II) complexes with HBr. The complexes [PtBr(H)Me₂(NN)] decomposed by reductive elimination of methane above −20 °C for bu₂bpy and from −20 to 0 °C for bpy analogue to give methane and platinum(II) complexes [PtBrMe(NN)] (5a)-(5b) and then decomposed at about 0 °C to yield [PtBr₂(NN)] and methane. When the reactions were performed at a molar ratio of Pt:RX/1:10, the corresponding complexes [PtBrMe(NN)] (5a)-(5b) were also obtained. The crystal structure of the complex 3b shows that platinum adopts square planar geometry with a twofold axis through the platinum atom. The Pt…Pt distance (5.164 Å) is considerably larger than the interplanar spacing (3.400 Å) and there is no platinum-platinum interaction.     

Synthesis, reactivities and catalytic carbonylation of rhodium(I) carbonyl complexes containing isomeric acetylpyridine ligands

[Rh(CO)₂Cl]₂ reacts with two mole equivalent of 2-acetylpyridine (a), 3-acetylpyridine (b) and 4-acetylpyridine (c) to afford chelate [Rh(CO)Cl(η²-N∩O)] (1a) and non-chelate [Rh(CO)₂Cl(η¹-N∼O)] (1b, 1c) complexes, where, N∩O = a, N∼O = b, c. Oxidative addition (OA) of 1a-1c with CH₃I and C₂H₅I yields penta coordinate rhodium(III) complexes, [Rh(COR)ClI(η²-N∩O)] {R = -CH₃ (2a); -C₂H₅ (3a)} and [Rh(COR)(CO)ClI(η¹-N∼O)] {R = -CH₃ (2b, 2c); -C₂H₅ (3b, 3c)}. Kinetic study for the reaction of 1a-1c with CH₃I indicates a pseudo-first order reaction. The catalytic activity of 1a-1c for the carbonylation of methanol to acetic acid and its ester was evaluated at different initial CO pressures 5, 10 and 20 bar at ∼25 °C and higher turn over numbers (TON = 1581-1654) were obtained compared to commercial Monsanto’s species [Rh(CO)₂I₂]⁻ (TON = 1000) under the reaction conditions: temperature = 130 ± 1 °C, pressure = 15-32 bar, rpm = 450, time = 1 h and catalyst: substrate = 1: 1900.     

Novel carbon-centered heteroscorpionate ligands: Cu(I) complexes and luminescence properties

Herein, we describe the synthesis of N,N′,S donor ligands 2-(1-(3,5-diisopropyl-1H-pyrazol-1-yl)-3-(methythio)propyl)-4-methoxy-3,5-dimethylpyridine (L1) and 2-(1-(3,5-diisopropyl-1H-pyrazol-1-yl)-2-(methythio)ethyl)-4-methoxy-3,5-dimethylpyridine (L2). Cu(I) complexes were prepared by reacting L1 or L2 with [Cu(CH₃CN)₄]BF₄ or CuCl. The coordination behavior of the thioether arm of the ligands was found to determine the nuclearity of the resulting complexes, in which [Cu(L1)PPh₃]BF₄ (1) is polynuclear, [Cu(L2)PPh₃]BF₄ (2) is mononuclear, while [Cu(L1)]₂(BF₄)₂ (3), [Cu(L2)CH₃CN]₂(BF₄)₂ (4), and [Cu(L1)Cl]₂ (5) are dinuclear. In the dimeric complex [Cu(L2)Cl]₂ (6), the sulfur atoms are not metal-bound. Rather, the two bridging chloride ions link the two copper centers. Compounds 4-6 are luminescent in the solid state, and exhibit emission bands centered at 490 nm (4), 544 nm (5), and 562 nm (6), respectively. Their excitation spectra display bands at 280 nm and 380 nm. According to DFT calculations, the HOMO is distributed partially over the metal centers and partially over the chloride anions (5 and 6) or the sulfur atoms (4) of the ligands, while the LUMO is a π∗ antibonding pyridine orbital. This suggests that the emission properties are derived from metal-to-ligand charge-transfer (MLCT), halide-to-ligand charge-transfer (XLCT), and ligand-to-ligand charge-transfer (LLCT) excited states.     

New amino-dithiaphospholanes and phosphoramidodithioites and their rhodium and iridium complexes

New sulfur derivatives of phosphoramidite ligands were synthesized and the impact of the sulfur unit on the spectroscopic properties of their rhodium and iridium complexes was investigated. The new ligands Bn₂NPSCH₂CH₂S^a(P-S^a) (Bn = benzyl, 4), Bn₂NPSCHCHS^a(CH₂)₃C^aH₂(P-S^a)(C^a-S^a) (6) and Bn₂NP(4-XC₆H₄OMe)₂ (X = S, 7a; X = O, 7b) were converted to the rhodium and iridium complexes trans-[Rh(CO)Cl(L)₂] (L = 4, 6, 7), [RhCl(COD)(L)] (L = 4, 6, 7), [IrCl(COD)(7a)] and [IrCl₂Cp∗(6)]. For comparison, some phosphoramidite complexes of these formulations also were synthesized. The new metal complexes were spectroscopically analyzed. For the carbonyl complexes, the ν_CO IR stretching frequencies were lower than for the corresponding phosphite and phosphoramidite ligands. The ¹J_PRh coupling constants for the rhodium complexes with the new ligands were also smaller than for the respective phosphoramidite and phosphite complexes. Finally, the ¹J_PSe coupling constants of the selenides of the new ligands were lower than those of the phosphoramidite ligands but higher than for PPh₃. The spectroscopic data reveal that the new thio ligands 4, 6 and 7a are more electron donating than phosphites and phosphoramidites but less electron donating than PPh₃.     

Study of the cytotoxic activity of di and triphenyltin(IV) carboxylate complexes

The reaction of 3-methoxyphenylacetic acid (3-MPAH), 4-methoxyphenylacetic acid (4-MPAH), 2,5-dimethyl-3-furoic acid (DMFUH) or 1,4-benzodioxane-6-carboxylic acid (BZDOH) with triphenyltin(IV) chloride (1:1) or diphenyltin(IV) dichloride (2:1) in the presence of triethylamine yielded the compounds [SnPh₃(3-MPA)] (1), [SnPh₃(4-MPA)] (2), [SnPh₃(DMFU)] (3), [SnPh₃(BZDO)] (4), [SnPh₂(3-MPA)₂] (5), [SnPh₂(4-MPA)₂] (6), [SnPh₂(DMFU)₂] (7) and [SnPh₂(BZDO)₂] (8), respectively. The tetranuclear complex [{Me₂(DMFU)SnOSn(DMFU)Me₂}₂] (9) was prepared by the reaction of dimethyltin(IV) oxide and 2,5-dimethyl-3-furoic acid (DMFUH). The molecular structures of 3, 4 and 9, were determined by X-ray diffraction studies. The cytotoxic activity of the carboxylic acids (3-MPAH, 4-MPAH, BZDOH and DMFUH) and di (5-8) and triphenyltin(IV) complexes (2-4) was tested against tumor cell lines human adenocarcinoma HeLa, human myelogenous leukemia K562, human malignant melanoma Fem-x and normal immunocompetent cells, peripheral blood mononuclear cells PBMC. Triphenyltin(IV) complexes show higher activities than the diphenyltin(IV) derivatives. The most active compound is [SnPh₃(DMFU)] (3) with IC₅₀ value of 0.15 ± 0.01, 0.051 ± 0.004, 0.074 ± 0.004, 0.20 ± 0.01, 0.15 ± 0.02 on HeLa, K562, Fem-x, rested and stimulated PBMC, respectively, while the most selective are [SnPh₂(3-MPA)₂] (5), [SnPh₂(DMFU)₂] (7) and [SnPh₂(BZDO)₂] (8). Compounds 3, 5, 7 and 8 present higher activities than cisplatin in all the tested cells and relative high selectivity especially on K562 cells.     

New pyridyl modified phosphines: Synthesis and late transition-metal coordination studies

Using a phosphorus based Mannich condensation reaction the new pyridylphosphines {5-Ph₂PCH₂N(H)}C₅H₃(2-Cl)N (1-Cl) and {2-Ph₂PCH₂N(H)}C₅H₃(5-Br)N (1-Br) have been synthesised in good yields (60% and 88%, respectively) from Ph₂PCH₂OH and the appropriate aminopyridine. The ligands 1-Cl and 1-Br display variable coordination modes depending on the choice of late transition-metal complex used. Hence P-monodentate coordination has been observed for the mononuclear complexes AuCl(1-Cl) (2), AuCl(1-Br) (3), RuCl₂(p-cymene)(1-Cl) (4), RuCl₂(p-cymene)(1-Br) (5), RhCl₂(Cp^∗)(1-Cl) (6), RhCl₂(Cp^∗)(1-Br) (7), IrCl₂(Cp^∗)(1-Cl) (8), IrCl₂(Cp^∗)(1′-Cl) (8′), IrCl₂(Cp^∗)(1-Br) (9), cis-/trans-PdCl₂(1-Cl)₂ (10), cis-/trans-PdCl₂(1-Br)₂ (11), cis-PtCl₂(1-Cl)₂ (12) and cis-PtCl₂(1-Br)₂ (13). Reaction of Pd(Me)Cl(cod) (cod = cycloocta-1,5-diene) with either 1 equiv. of 1-Br or the known pyridylphosphines 1′-Cl, 1-OH or 1-H gave the P/N-chelate complexes Pd(Me)Cl(1-Br-1-H) (14)-(17). All new compounds have been fully characterised by spectroscopic and analytical methods. Furthermore the structures of 4, 5, 10 and 16 · (CH₃)₂SO have been elucidated by single crystal X-ray crystallography. A crystal structure of the dinuclear metallocycle trans,trans-[PdCl₂{μ-P/N-{Ph₂PCH₂N(H)}C₅H₄N}]₂ · CHCl₃, 18 · CHCl₃, has also been determined. Here 1-H bridges, using both P and pyridyl N donors, two dichloropalladium centres affording a 12-membered ring with the PdCl₂ units adopting a head-to-tail arrangement.     

Syntheses, characterizations and theoretical calculations of rhodium(III) 1,2-naphthoquinone-1-oxime complexes

Rhodium(III) complexes of 1,2-naphthoquinone-1-oxime (1-nqo) [Rh(1-nqo)L₂Cl₂] 1-3 [1, L = 4-methylpyridine (mpy); 2, L = 4-phenylpyridine (ppy); 3, L = 4-acetylpyridine (apy)] were prepared. The structure of complex 1 is analyzed by single crystal X-ray crystallography. All of the complexes were characterized by mass spectrometry, ¹H-¹H COSY NMR and FT-IR. UV-Vis absorption spectroscopy and cyclic voltammetry were employed to investigate the electronic transition behaviors of the complexes. The complexes displayed irreversible metal-localized two-electron reductions from Rh^III to Rh^I on the cyclic voltammogram. While the low-energy absorptions at λ_max of 488-490 nm on the UV-Vis spectra of the complexes were related to metal to 1-nqo ligand charge transfer [MLCT, dπ(Rh) → π∗(1-nqo)] and chloride to 1-nqo ligand charge transfer [LLCT, pπ(Cl) → π∗(1-nqo)] based on the theoretical calculations using time-dependent density functional theory (TD-DFT).     

Palladium(II), platinum(II), ruthenium(II) and mercury(II) complexes of potentially tridentate Schiff base ligands of (E, N, O) type (E = S, Se, Te): Synthesis, crystal structures and applications in Heck and Suzuki coupling reactions

Schiff bases of 2-hydroxybenzophenone (HBP) (C₆H₅)(2-HOC₆H₄)CN(CH₂)_nEAr (L1/L2: E = S, Ar = Ph, n = 2/3; L3/L4: E = Se, Ar = Ph, n = 2/3; L5/L6: E = Te, Ar = 4-MeOC₆H₄, n = 2/3) and their complexes [PdCl(L-H)] (L = L1−L6; 1, 2, 3, 5, 7, 11), [PtCl(L3-H/L5-H)] (4/8), [PtCl₂(L4/L6)₂] (6/12), [(p-cymene)RuCl(L5/L6)]Cl (9/13) and [HgBr₂(L5/L6)₂] (10/14) have been synthesized and characterized by proton, carbon-13, selenium-77 and tellurium-125 NMR, IR and mass spectra. Single crystal structures of L1, 1, 3, 4, 5 and 7 were solved. The Pd-E bond distances (Å): 2.2563(6) (E = S), 2.3575(6)−2.392(2) (E = Se); 2.5117(5)−2.5198(5) (E = Te) are near the lower end of the bond length range known for them. The Pt-Se bond length, 2.3470(8) Å, is also closer to the short values reported so far. The Heck and Suzuki reaction were carried out using complexes 1, 3, 5 and 7 as catalysts under aerobic condition. The percentage yields for trans product in Heck reaction were found upto 85%.     

Rhenium(III) and technetium(III) complexes with 2-mercapto-1,3-azole ligands and X-ray crystal structures

Reactions of labile [MCl₃(PPh₃)₂(NCMe)] (M = Tc, Re) precursors with 1H-benzoimidazole-2-thiol (H₂L¹), 5-methyl-1H-benzoimidazole-2-thiol (H₂L²) and 1H-imidazole-2-thiol (H₂L³), in the presence of PPh₃ and [AsPh₄]Cl gave a new series of trigonal bipyramidal M(III) complexes [AsPh₄]{[M(PPh₃)Cl(H₂L^1-3)₃]Cl₃} (M = Re, 1-3; M = Tc, 4-6). The molecular structures of 1 and 3 were determined by X-ray diffraction. When the reactions were carried out with benzothiazole-2-thiol (HL⁴) and benzoxazole-2-thiol (HL⁵), neutral paramagnetic monosubstituted M(III) complexes [M(PPh₃)₂Cl₂(L^4,5)] (M = Re, 8, 9; M = Tc, 10, 11) were obtained. In these compounds, the central metal ions adopt an octahedral coordination geometry as authenticated by single crystal X-ray diffraction analysis of 8 and 11. Rhenium and technetium complexes 1, 4 and rhenium chelate compounds 8, 9 have been also synthesized by reduction of [MO₄]⁻ with PPh₃ and HCl in the presence of the appropriate ligand. All the complexes were characterized by elemental analyses, FTIR and NMR spectroscopy.